Trials / Completed
CompletedNCT02125669
Pulsed Dye Laser in Treating Superficial Basal Cell Carcinomas
The Role of the 595 nm Pulsed Dye Laser in Treating Superficial Basal Cell Carcinomas at Low Risk Anatomical Sites: Outcome of a Double Blind Randomized Placebo Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Hautklinik Darmstadt · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Pulsed dye laser (PDL) treatments have been suggested to be a safe and effective therapeutic approach for treating basal cell carcinomas. Robust supporting evidence is, however, lacking due to inconsistent design of available studies. The purpose of this study is to evaluate the PDL's efficacy and safety in treating superficial basal cell carcinoma (sBCC) at low risk anatomical sites in an evidence based study setting.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Laser treatment | Pulsed dye laser 595nm |
| DEVICE | SHAM-Treatment | using the pulsed dye laser (PDL) laser without releasing a pulse |
Timeline
- Start date
- 2012-11-01
- Primary completion
- 2013-09-01
- Completion
- 2013-09-01
- First posted
- 2014-04-29
- Last updated
- 2014-04-29
Source: ClinicalTrials.gov record NCT02125669. Inclusion in this directory is not an endorsement.